Instructions for Authors on the Preparation and Submission of Manuscripts to AIDS
Note: These instructions comply with those formulated by the International Committee of Medical Journal Editors. For further details, authors should consult the "Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals" at www.icmje.org.
The Journal is a member of the Committee on Publication Ethics (COPE) which aims to define best practice in the ethics of scientific publishing. COPE has established a number of guidelines as part of a set of Core Practices (www.publicationethics.org).
Appeals on editorial decisions should be sent to the Editor. Complaints related to how your paper was processed during peer-review and not resolved by the Editor, should be referred to the person named as publisher in "About the Journal" under "Journal Info" contacts (http://journals.lww.com/aidsonline/) or if unsatisfied to COPE (www.publicationethics.org).
This Journal allows authors to choose an Open Access option for their published article on payment of a fee. See the Open Access section below.
SCOPE
AIDS publishes papers reporting original scientific, clinical, epidemiological, and social research which are of a high standard and contribute to the overall knowledge of the field of the acquired immune deficiency syndrome. The Journal publishes Original Papers, Concise Communications, Field Notes, Research Letters, and Correspondence, as well as invited Editorial Reviews, Opinion Pieces, Viewpoints, Editorial Comments, and Fast Track articles. Fast Track is designed for publication, in the fastest time possible, of original short papers that contain important and time-sensitive information. All manuscript submissions to the regular issues and supplements of the journal are peer-reviewed. Submitted articles undergo a preliminary review by the editors. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editor and/or other editors and selected reviewers. Papers may be subject to a statistical analysis and for flow cytometry results by a group of experts in the field. Case Reports are not encouraged but may be considered as Correspondence letters.
SUBMISSIONS
Authors should submit their manuscripts through the web-based tracking system at http://aids.edmgr.com/. The site contains instructions and advice on how to use the system. Authors should NOT in addition then post a hard copy submission to the editorial office.
Double spacing should be used throughout the manuscript, which should include the following sections, each starting on a separate sheet: Title Page, abstract (when required) and keywords, text, acknowledgements, references, individual tables and captions. Margins should be at least 3 cm. Pages should be numbered consecutively, beginning with the Title Page, and the page number should be placed in the top right-hand corner of each page. Abbreviations should be defined on their first appearance in the text; those not accepted by international bodies should be avoided. The word count should be clearly stated on the Title Page.
Authors are invited to list up to four potential reviewers, including their full addresses, telephone and fax numbers, and e-mail addresses.
A Fast Track option is available for papers that contain time-sensitive and important information.
Non-native speakers of English: Authors who are not native speakers of English and require help in writing an article in English are encouraged to seek assistance from a qualified colleague or consider using a language service in preparing a manuscript submission. Wolters Kluwer, in partnership with Editage, offers such services - for more information please visit http://wkauthorservices.editage.com. Please note that the use of this or other services are at the author's own expense and risk, and independent from the editorial processes of this journal, and does not guarantee that an article will be accepted for publication.
Article Types
Fast Track
Papers should report original time-sensitive findings that merit special attention. Abstracts of the papers are first considered and authors are notified within 48 hours if the full article should be submitted. The full article is then reviewed within 14 days and if accepted, is published in the next issue of AIDS. Text should not exceed 2,500 words with up to five figures and tables. Authors should submit their structured abstract to our submission system (https://www.editorialmanager.com/aids/default.aspx) using the Fast Track Proposal article type. Full Fast Track guidelines can be found here: http://edmgr.ovid.com/aids/accounts/AIDSFastTrack.doc
Original papers
Manuscripts should be concise and not be more than 3500 words, with up to five figures or tables. Papers will be returned if they exceed the maximum stated. The word limit refers to the main body of the text and does not include the abstract, references or figure legends.
Concise Communications
Original research findings that do not require a full paper, but are completed studies, may be submitted as Concise Communications. Papers should not exceed 1800 words, and may be accompanied by a maximum of two inserts only (figures/tables). Papers submitted for consideration as Concise Communications should be clearly identified in the author’s covering letter.
Research letters
Research Letters provide a forum for original research results, excluding case reports, and observations that merit publication and can be reported succinctly. Research letters are reviewed by the Editors or external reviewers. Research letters should include a summary of up to 75 words, not exceed 1000 words (excluding summary) and not have more than one figure or table.
Correspondence
The correspondence section is reserved for case reports, and letters that are addressing issues or exchanging views on topics arising from published articles in the journal. Correspondence should not exceed 750 words and not have more than one figure or table. These letters are subject to review by the Editors, and may be rejected without written explanation. In some instances, correspondence will be peer-reviewed.
Editorial Reviews
AIDS features reviews on various topics in HIV/AIDS. These articles are invited by the editors. Individuals can write to the editors to ask about an interest in a review. If approved, they will be then officially invited to write one. The instructions are subsequently provided by the Editorial office.
Opinion Piece and Viewpoint
The Journal will consider articles that review in detail the literature on a topic and give an opinion of an author (s) on that particular area of HIV/AIDS. The Opinion Pieces should be limited to 2500 words and can have up to four illustrations or tables.
A Viewpoint is a brief description of an issue in HIV/AIDS and the opinion of the author (s) on that issue. Viewpoints are limited to 1500 words and can have one figure or table.
The papers will be subject to the same review process as other original articles. Opinion Pieces and Viewpoint articles should NOT include an abstract.
Field Notes
Articles describing experiences with diagnosing and treating HIV infection and its accompanying opportunistic infections and cancers will be considered for this section of the journal. These contributors should report personal experiences and give insight into the way culture and medical care within a particular part of the world influences the approaches taken for HIV/AIDS. Preference is given to individuals working in developing countries. The length should be no longer than 1500 words and can have up to 4 illustrations. Field Notes articles should NOT include an abstract. Please indicate this section when submitting the manuscript.
According to AIDS Editorial policy, the Editors will not enter into direct correspondence regarding a submission to the journal. Where clarification about a decision is requested, all communications should be made in writing and directed to the Editorial Office (aids@wolterskluwer.com). The Journal is a member of the Committee on Publication Ethics (COPE) which aims to define best practice in the ethics of scientific publishing. COPE has established a number of guidelines as part of a set of Core Practices (www.publicationethics.org).
Appeals on editorial decisions should be sent to the Editorial Office. Complaints related to how your paper was processed during peer-review and not resolved by the Editor through the Editorial Office, should be referred to the person named as publisher in "Journal Info" contacts (http://journals.lww.com/aidsonline/Pages/aboutthejournal.aspx), or if unsatisfied to COPE (www.publicationethics.org).
POINTS TO CONSIDER BEFORE SUBMISSION
Redundant or duplicate publication
Submissions are accepted on the understanding that they have not been published in their current form or a substantially similar form (in print or electronically, including on a web site), that they have not been accepted for publication elsewhere, and they are not under consideration by another publication. If you are in doubt (particularly in the case of material that you have posted on a web site or an abstract of your work), we ask you to proceed with your submission but to include a copy of the relevant previously published work or work under consideration by other journals.
Preprints: Work posted on a preprint server, which identifies a preprint as not peer-reviewed, will be considered for publication. The author should declare preprint server deposition on submitting their article to the Journal. If the article is accepted, to ensure readers can find and cite the final published version, authors should add the Digital Object Identifier (DOI) of the published journal article to the posted preprint version.
Conflicts of interest
Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading "Conflicts of Interest and Source of Funding:". For example:
Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker’s bureau for Organization X – the CME organizers for Company A. For the remaining authors none were declared.
Each author must complete and submit the journal's copyright transfer agreement, which includes a section on the disclosure of potential conflicts of interest based on the recommendations of the International Committee of Medical Journal Editors(www.icmje.org/update.html). The copyright agreement is included in the Author Questionnaire, completed by the submitting author within the Editorial Manager submission process. Co-authors will automatically receive an Email with a link to the questionnaire upon submission.
Permissions to reproduce previously published material
Authors must obtain prior permission to reproduce material published elsewhere (such as illustrations) from the copyright holder. The granting of permission should be acknowledged alongside the material (e.g., legend of a figure) in the submitted article. Authors are responsible for paying any fees to reproduce material.
Subject consent
Subjects have a right to privacy that should not be infringed without informed consent. Informed consent should be obtained from patients or other subjects of experiments that clearly grants permission for the publication of photographs or other material that might identify them. If the consent form for your research did not specifically include this, please obtain it or remove the identifying material. Identifying details (written or photographic) should be omitted if they are not essential, but subject data should never be altered or falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve. For example, masking the eye region in photographs of subjects is inadequate protection of anonymity. When informed consent has been obtained, it should be indicated in the submitted article.
Ethics committee approval
All authors must sign a declaration that the research was conducted within the guidelines below and under the terms of all relevant local legislation. Please also look at the latest version of the Declaration of Helsinki (www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/). The Editors reserve the right to judge the appropriateness of the use and treatment of humans or animals in experiments for publication in the journal.
Human experiments: All work must be conducted in accordance with the Declaration of Helsinki. Papers describing experimental work on human participants which carries a risk of harm must include (1) a statement that the experiments were conducted with the understanding and the consent of each participant, and (2) a statement that the responsible ethical committee has approved the experiments.
Animal experiments: In papers describing experiments on living animals, include (1) a full description of any anaesthetic and surgical procedure used, and (2) evidence that all possible steps were taken to avoid animals' suffering at each stage of the experiment. In experiments involving the use of muscle relaxants, describe the precautions taken to ensure adequate anaesthesia. Authors should follow current guidelines on the acquisition, care and use of laboratory animals such as the National Academy of Sciences, "Guide for the Care and Use of Laboratory Animals".
Experiments on isolated tissues: Indicate precisely how you obtained the donor tissue.
Clinical trials, data sharing and behavioural evaluations
Authors reporting results of randomized controlled trials should include with their submission a complete checklist from the CONSORT statement, see http://www.consort-statement.org. For behavioural and public health evaluations involving non-randomized designs, authors should include with their submission a complete checklist from the TREND statement, see http://www.cdc.gov/trendstatement/.
Registration of clinical trials: As a condition for publication of a clinical trial in AIDS, registration of the trial in a public registry is required. Registration of a trial must be at or before the enrolment of participants. We will use the definition adopted by the ICMJE of a clinical trial 'as any research project that prospectively assigns people or a group of people to an intervention, with or without concurrent comparison or control groups, to study the cause-and-effect relationship between a health-related intervention and a health outcome'. Studies such as phase 1 trials will be exempt. The editors of AIDS also do not advocate one particular registry but require that the registry utilized meet the criteria set out in the statement of policy of the ICMJE.
……
更多详情：
https://edmgr.ovid.com/aids/accounts/ifauth.htm
